Anemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Anemia in Chronic Kidney Disease (Renal Anemia) – Drugs In Development, 2024 report and make more profitable business decisions.
Renal anemia is a disease in which the patient has an unusually low count of red blood cells associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein produced in the kidneys that helps to create red blood cells. Symptoms caused by renal anemia include pale skin and gums, shortness of breath, dizziness, and inability to think clearly.
The Anemia in Chronic Kidney Disease (Renal Anemia) drugs in development market research report provide comprehensive information on the therapeutics under development for Anemia in Chronic Kidney Disease (Renal Anemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anemia in Chronic Kidney Disease (Renal Anemia) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Anemia in Chronic Kidney Disease (Renal Anemia) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 41 molecules, with 40 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Anemia in Chronic Kidney Disease (Renal Anemia) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Anemia in Chronic Kidney Disease (Renal Anemia) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Anemia in Chronic Kidney Disease (Renal Anemia) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
3SBio IncAkebia Therapeutics Inc
Angde Biotech Pharmaceutical Co Ltd
Avesthagen Ltd
Biocad
China Pharmaceutical Research and Development Center Co Ltd
China Pharmaceutical University
Chong Kun Dang Pharmaceutical Corp.
Disc Medicine Inc
Dong-A Socio Holdings Co Ltd
EPOK Therapeutics Inc
FibroGen Inc
General Biologics Inc
Genexine Inc
GSK plc
HEC Pharma Co Ltd
Imagine Pharma LLC
InSilico Medicine
Jaku (Shanghai) Biomedical Research Co Ltd
Jecho Biopharmaceuticals Co Ltd
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Kind Pharmaceuticals
Liminal BioSciences Inc
Mitsubishi Tanabe Pharma Corp
Modus Therapeutics AB
North China Pharmaceutical Co Ltd
Panacea Biotec Ltd
Panion & Bf Biotech Inc
PharmaEssentia Corp
PhytoHealth Corp
PT Kalbe Genexine Biologics
Serum Institute of India Pvt Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
SunBio Inc
SynBio
UBI Pharma Inc
Uni-Bio Science Group Ltd
Xiamen Boruilai Pharmaceutical Technology Co Ltd
YL Biologics Ltd
Zosano Pharma Corp
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions